The AJMC® Diabetes compendium is a comprehensive resource for clinical news and expert insights for the chronic condition.
March 8th 2024
A survey of more than 1500 people revealed misconceptions about living with diabetes, particularly regarding the efficacy of GLP-1 weight loss drugs as a standalone solution for managing their health goals.
Gene Factors Into Sex-Related Differences in Cognition Loss in Presence of T2D
April 17th 2021Among patients with type 2 diabetes (T2D) and weight issues, cognitive advantages that women hold over men when both are affected are preserved into later life but are eroded for women carrying apolipoprotein E ε4 alleles.
Read More
Examination of Marshallese Living in US Illustrates Health Disparities in T2D
April 10th 2021A high proportion of Marshallese, or Marshall Islanders, living on the mainland Unites States, have undiagnosed hypertension and type 2 diabetes (T2D), according to findings that will be used to address disparities in Native Hawaiian and Pacific Islander populations.
Read More
Low-Carb Diet May Help Achieve Type 2 Diabetes Remission, Study Finds
April 1st 2021A review found that a low-carbohydrate diet may lead patients with type 2 diabetes to experience disease remission, potentially providing new insight into how clinicians can help patients better manage their disease, investigators concluded.
Read More
20-Year Data Highlight Little Progress in Rural Racial Health Disparities
March 15th 2021Between 1999 and 2018, Black adults living in rural regions of the United States experienced high mortality rates due to diabetes, high blood pressure, heart disease, and stroke compared with White adults, according to new research published in the Journal of the American College of Cardiology.
Read More
Comparing T2D Medication Initiation Patterns Among Medicare Advantage, Commercially Insured Patients
March 12th 2021Medicare Advantage beneficiaries with type 2 diabetes (T2D) may be less likely than commercially insured individuals to be treated with newer medications to lower glucose levels, according to results of a retrospective cohort study published in JAMA Network Open.
Read More
Behavior-Based Diabetes Management: Impact on Care, Hospitalizations, and Costs
The Diabetes Care Rewards program offers a business case for health plans to promote engagement through use of contingent incentives, thus improving health outcomes and lowering costs.
Read More
How Do Screening Methods for Gestational Diabetes Compare?
March 10th 2021When comparing 1-step and 2-step approaches for diagnosing gestational diabetes among pregnant women, researchers found no significant between-group differences in the risks of primary outcomes relating to perinatal and maternal complications.
Read More
Costs for Commercially Insured Adults Prescribed Second-line Diabetes Medications
Adults with type 2 diabetes who received nonsulfonylurea medications had relative increases in total costs. Receiving newer medication classes led to relatively decreased medical costs.
Read More
Exercise Timing Linked to Cardiorespiratory Fitness in Men With T2D
March 2nd 2021Timing of bout-related moderate-to-vigorous physical activity (MVPA) is associated with cardiorespiratory fitness and cardiovascular risk among men with type 2 diabetes (T2D), independent of bout-related MVPA volume and intensity, according to research published in Diabetes Care.
Read More
Caring for the Whole Patient With Diabetes Drives ChristianaCare Pilot Success
March 1st 2021Collaboration enabled ChristianaCare to significantly grow its population of patients with well-controlled disease, thanks to a diabetes control roadmap that ensured both physical and emotional health needs were met through interprofessional partnerships.
Read More
Phase 3 Trials Show Lilly’s Tirzepatide Reduces A1C, Body Weight Among Patients With T2D
February 18th 2021The SURPASS program, which consists in part of SURPASS-3 and SURPASS-5, is testing the efficacy and safety of tirzepatide, a novel investigational once-weekly dual glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 receptor agonist.
Read More
GD May Increase Heart Disease Risk Despite Achieving Normal Blood Glucose Levels
February 3rd 2021Results of a prospective cohort study suggest history of gestational diabetes (GD) may promote development of atherosclerotic plaque, potentially increasing the risk of future heart disease among women, even in the absence of hyperglycemia.
Read More
Insulin Resistance, Diabetes Strongly Linked With Premature CHD Among Women
January 27th 2021A prospective cohort study found that diabetes and insulin resistance were the strongest risk factors for premature onset of coronary heart disease (CHD) among American women. Results were published in JAMA Cardiology.
Read More
Metabolic Surgery Superior to Drug Therapy at Controlling Type 2 Diabetes, Study Says
January 25th 2021Metabolic surgery is more effective than conventional medical therapy in the long-term control of type 2 diabetes (T2D), according to results of a 10-year follow-up study of a randomized controlled trial published in The Lancet.
Read More
Study Weighs Perceived Benefits, Costs of RDM Adoption for Diabetes Management
January 20th 2021Results of a vignette-based survey study indicate patients with diabetes require greater health benefits to adopt more intrusive remote digital monitoring (RDM), food monitoring, and real-time feedback by a health care professional.
Read More
Trial Finds Bimagrumab Aids Weight Loss in Patients With T2D, Obesity
January 18th 2021Results of a phase 2 trial showed that an activin type II receptor blockade, achieved via bimagrumab, led to significant loss of fat mass, gain in lean mass, and metabolic improvements among patients with type 2 diabetes (T2D) and overweight or obesity.
Read More
Black Americans With T1D, COVID-19 Have Increased Risk of Hospitalization for DKA
January 13th 2021Non-Hispanic Black individuals with type 1 diabetes and coronavirus disease 2019 infections may be more likely to be hospitalized for diabetic ketoacidosis (DKA) compared with non-Hispanic White patients.
Read More